Cargando…
miR-939 acts as tumor suppressor by modulating JUNB transcriptional activity in pediatric anaplastic large cell lymphoma
Autores principales: | Garbin, Anna, Lovisa, Federica, Holmes, Antony B., Damanti, Carlotta C., Gallingani, Ilaria, Carraro, Elisa, Accordi, Benedetta, Veltri, Giulia, Pizzi, Marco, d’Amore, Emanuele S.G., Pillon, Marta, Biffi, Alessandra, Basso, Katia, Mussolin, Lara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849582/ https://www.ncbi.nlm.nih.gov/pubmed/32299901 http://dx.doi.org/10.3324/haematol.2019.241307 |
Ejemplares similares
-
RNY4 in Circulating Exosomes of Patients With Pediatric Anaplastic Large Cell Lymphoma: An Active Player?
por: Lovisa, Federica, et al.
Publicado: (2020) -
Increased Tenascin C, Osteopontin and HSP90 Levels in Plasmatic Small Extracellular Vesicles of Pediatric ALK-Positive Anaplastic Large Cell Lymphoma: New Prognostic Biomarkers?
por: Lovisa, Federica, et al.
Publicado: (2021) -
Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients
por: Veltri, Giulia, et al.
Publicado: (2021) -
Plasma small‐extracellular vesicles enriched in miR‐122‐5p promote disease aggressiveness in pediatric anaplastic large‐cell lymphoma
por: Damanti, Carlotta Caterina, et al.
Publicado: (2023) -
Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience
por: Lovisa, Federica, et al.
Publicado: (2021)